© 1995 Oxford University Press
research-article |
Rosemary components inhibit benzo[a]pyrene-induced genotoxicity in human bronchial cells
Nestlé Research Centre PO Box 44, CH-1000 Lausanne 26, Switzerland
1To whom correspondence should be addressed
The commonly used spice and flavouring agent, rosemary, derived from the leaves of the plant Rosmarinus officinalis L., displays antioxidant properties in foods and in biological systems. Moreover, in animal models rosemary components were found to inhibit the initiation and tumour promotion phases of carcinogenesis. In this work, we studied the mechanisms by which rosemary components block initiation of carcinogenesis by the procarcinogen benzo[a]pyrene (B[a]P) in human bronchial epithelial cells (BEAS-2B). Whole rosemary extract (6 µg/ml) or an equivalent concentration of its most potent antioxidant constituents, carnosol or carnosic acid, inhibited DNA adduct formation by 80% after 6 h co-incubation with 1.5 µM B[a]P. Under similar conditions, cytochrome P450 (CYP) 1A1 mRNA expression was 50% lower in the presence of rosemary components, and CYP1A1 activity was inhibited 70–90%. The observed reduction of DNA adduct formation by rosemary components may mostly result from the inhibition of the activation of benzo[a]pyrene to its ultimate metabolites. Carnosol also affected expression of the phase II enzyme glutathione-S-transferase which is known to detoxify the proximate carcinogenic metabolite of B[a]P. Treatment of BEAS-2B cells with carnosol (1 µg/ml) for 24 h resulted in a 3- to 4-fold induction of GST
mRNA. Moreover, expression of a second important phase II enzyme, NAD(P)H: quinone reductase, was induced by carnosol in parallel with GST. Therefore, rosemary components have the potential to decrease activation and increase detoxification of an important human carcinogen, identifying them as promising candidates for chemopreventive programs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. A. Scheckel, S. C. Degner, and D. F. Romagnolo Rosmarinic Acid Antagonizes Activator Protein-1-Dependent Activation of Cyclooxygenase-2 Expression in Human Cancer and Nonmalignant Cell Lines J. Nutr., November 1, 2008; 138(11): 2098 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Alexandrov, M. Rojas, and C. Rolando DNA Damage by Benzo(a)pyrene in Human Cells Is Increased by Cigarette Smoke and Decreased by a Filter Containing Rosemary Extract, Which Lowers Free Radicals Cancer Res., December 15, 2006; 66(24): 11938 - 11945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Tsuji and T. Walle Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids Carcinogenesis, August 1, 2006; 27(8): 1579 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Moran, A. M. Carothers, M. J. Weyant, M. Redston, and M. M. Bertagnolli Carnosol Inhibits {beta}-Catenin Tyrosine Phosphorylation and Prevents Adenoma Formation in the C57BL/6J/Min/+ (Min/+) Mouse Cancer Res., February 1, 2005; 65(3): 1097 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Van Vleet, K. Mace, and R. A. Coulombe Jr. Comparative Aflatoxin B1 Activation and Cytotoxicity in Human Bronchial Cells Expressing Cytochromes P450 1A2 and 3A4 Cancer Res., January 1, 2002; 62(1): 105 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Reimer, C. Darimont, S. Gremlich, V. Nicolas-Metral, U. T. Ruegg, and K. Mace A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion Endocrinology, October 1, 2001; 142(10): 4522 - 4528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Mashour, G. I. Lin, and W. H. Frishman Herbal Medicine for the Treatment of Cardiovascular Disease: Clinical Considerations Arch Intern Med, November 9, 1998; 158(20): 2225 - 2234. [Abstract] [Full Text] [PDF]
|
|